QUOTIENT PHARMACEUTICALS MANUFACTURING

quotient-pharmaceuticals-manufacturing-logo

Quotient Pharmaceuticals Manufacturing is a biopharmaceutical company providing various types of pharmaceutical manufacturing services.

#SimilarOrganizations #Website #More

QUOTIENT PHARMACEUTICALS MANUFACTURING

Social Links:

Industry:
Biotechnology Consulting Health Care Manufacturing Pharmaceutical

Founded:
2000-01-01

Address:
Anaheim, California, United States

Country:
United States

Website Url:
http://www.quotientpharma.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
Amazon GoDaddy DNS Amazon Virginia Region AWS Global Accelerator AppRiver


Similar Organizations

allstar-health-brands-inc-logo

Allstar Health Brands Inc

AllStar Health Brands is a pharmaceutical company that manufactures and distributes pharmaceutical and natural health products.

biopharma-connections-logo

BioPharma Connections

BioPharma Connections is an independent, woman-owned, San Francisco-based biopharmaceutical consulting company.

emcure-pharmaceuticals-usa-inc-logo

Emcure Pharmaceuticals USA, Inc

Emcure Pharmaceuticals USA is a pharmaceuticals company providing product identification services.

pharmaceutical-outsourcing-logo

Pharmaceutical Outsourcing

Pharmaceutical Outsourcing specializes in pharmaceutical and biopharmaceutical contract services.

pharmaceutical-processing-logo

Pharmaceutical Processing

Pharmaceutical Processing is the leading source of pharmaceutical and biopharmaceutical manufacturing news.

Official Site Inspections

http://www.quotientpharma.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Quotient Pharmaceuticals Manufacturing"

Our History - QUOTIENT PHARMACEUTICALS โ€ฆ

Over 250 million doses of RhoGAM have been given safely and it completely blocks the response virtually every time. Dr. Pollack also led the development of Hepatitis B Immune Globulin (HBIG), which confers immediate passive hyper โ€ฆSee details»

Leadership - QUOTIENT PHARMACEUTICALS โ€ฆ

Quotient is proud of its team and their collective work for numerous companies, universities, and hospitals around the world. The Company has assembled a team of visionary entrepreneurs with extensive business acumen and a team โ€ฆSee details»

Pharmaceutical CDMO & CRO | Quotient Sciences

Streamline your drug development outsourcing and get your therapy to patients, fast. Quotient Sciences is a trusted partner that can take your lead molecule from candidate selection, to first-in-human clinical testing, all the way through to โ€ฆSee details»

Quotient Pharmaceuticals Manufacturing - Crunchbase

Quotient Pharmaceuticals Manufacturing is a biopharmaceutical company providing various types of pharmaceutical manufacturing services.See details»

At A Glance | About Us | Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator supporting customers across the entire development pathway from candidate selection to commercial launch.See details»

Quotient Clinical Rebrands as Quotient Sciences - Pharma โ€ฆ

Nov 14, 2017 Quotient Clinical, the drug development services organization, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS โ€ฆSee details»

Quotient Pharmaceuticals Manufacturing - Drug pipelines, Patents ...

Explore Quotient Pharmaceuticals Manufacturing with its drug pipeline, therapeutic area, technology platform, .See details»

Commercial Manufacturing - What We Do | Quotient Sciences

Leverage our expertise to help you transfer your existing products and processes from another contract development and manufacturing organization (CDMO). Our integrated approach โ€ฆSee details»

Quotient Sciences to Recapitalize With Global Private Equity

Organization, delivers innovative, customized solutions for over 150 pharmaceutical and biotech customers through both individual and integrated services. Quotient has more than 850 โ€ฆSee details»

Pharma Tech Outlook: Pharma Tech Magazine - pharma-and-life โ€ฆ

The companyโ€™s Translational Pharmaceutics ® platform is one exemplar, integrating formulation development, real-time manufacturing and clinical testing, thereby reducing development โ€ฆSee details»

Quotient Acquires QS Pharma | Technology Networks

Feb 14, 2017 Quotient Clinical (โ€œQuotientโ€), the early phase drug development services provider, today announces that it has acquired QS Pharma, the contract development and โ€ฆSee details»

Quotient's streamlined drug development process saves months

Feb 11, 2022 This integration under one organization allows for seamless coordination and knowledge sharing, ease of material transfer, and a reduction in overall project risk. Some โ€ฆSee details»

QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG โ€ฆ

Feb 17, 2022 Quotient Sciences Translational Pharmaceutics ® approach โ€“ combining manufacturing and clinical dosing at a single organization โ€“ enables innovators to adjust โ€ฆSee details»

Quotient Sciences Opens New Early-Phase Formulation and

Oct 30, 2018 Quotient Sciences, a drug development services organization, has expanded its operations in the United States with the opening of a state-of-the-art, 45,000-ft 2 facility โ€ฆSee details»

Quotient Sciences Completes Integration of Drug Substance Into ...

We remain the only outsourcing partner able to offer innovators the ability to manufacture, release, and dose under one organization. This approach is proven to shave 12-months off โ€ฆSee details»

Quotient Sciences casts $8.7M spell over its new Alnwick facility ...

Sep 2, 2021 But the company isnโ€™t stopping there. The drugmaker plans to funnel £6.3 million (about $8.7 million) into the facility, which will conjure up an additional 80 jobs over the next โ€ฆSee details»

Flagship Pioneering Unveils Quotient Therapeutics to Create ...

Nov 21, 2023 "The assumption that we each have a single genome turns out to be off by a trillion-fold," said Geoffrey von Maltzahn, Ph.D., Co-Founder and Chief Executive Officer of โ€ฆSee details»

Drug Development: Accelerate Your Program | Quotient Sciences

Due to the low density and poor flow characteristics of our drug substance, we experienced significant blend and content uniformity issues. By transferring our program to Quotient โ€ฆSee details»

linkstock.net © 2022. All rights reserved